CoChat
Sign Up
Cited by 93

The DOI matches its Crossref record; 3 of the 3 references it cites were found in a registry or an index.

Potently cytotoxic natural killer cells initially emerge from erythro‐myeloid progenitors during mammalian development

Dege, Carissa, Fegan, Katherine H., Creamer, J. Philip, Berrien-Elliott, Melissa M., Luff, Stephanie A., Kim, Darren, Wagner, Julia A., Kingsley, Paul D., McGrath, Kathleen E., Fehniger, Todd A., Palis, James, Sturgeon, Christopher M.·2020·Developmental Cell
DOI 10.1016/j.devcel.2020.02.016PMC PMC7185477
Open this paper in CoChat — free account

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/j.devcel.2020.02.016

Cites

3 of 3 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Research works printed but not linked: 49

  1. Allan, 2017, Transcriptome analysis reveals similarities between human blood CD3- CD56bright cells and mouse CD127+ innate lymphoid cells, Sci. Rep., 7, 3501, 10.1038/s41598-017-03256-0 · DOI
  2. Alter, 2004, CD107a as a functional marker for the identification of natural killer cell activity, J. Immunol. Methods, 294, 15, 10.1016/j.jim.2004.08.008 · DOI
  3. Bertrand, 2005, Three pathways to mature macrophages in the early mouse yolk sac, Blood, 106, 3004, 10.1182/blood-2005-02-0461 · DOI
  4. Bertrand, 2007, Definitive hematopoiesis initiates through a committed erythromyeloid progenitor in the zebrafish embryo, Development, 134, 4147, 10.1242/dev.012385 · DOI
  5. Böiers, 2013, Lymphomyeloid contribution of an immune-restricted progenitor emerging prior to definitive hematopoietic stem cells, Cell Stem Cell, 13, 535, 10.1016/j.stem.2013.08.012 · DOI
  6. Caligiuri, 2008, Human natural killer cells, Blood, 112, 461, 10.1182/blood-2007-09-077438 · DOI
  7. Chen, 2015, Delineation of natural killer cell differentiation from myeloid progenitors in human, Sci. Rep., 5, 15118, 10.1038/srep15118 · DOI
  8. Creamer, 2017, Human definitive hematopoietic specification from pluripotent stem cells is regulated by mesodermal expression of CDX4, Blood, 129, 2988, 10.1182/blood-2016-11-749382 · DOI
  9. Crinier, 2018, High-dimensional single-cell analysis identifies organ-specific signatures and conserved NK cell subsets in humans and mice, Immunity, 49, 971, 10.1016/j.immuni.2018.09.009 · DOI · Paper page
  10. Dege, 2017, Directed differentiation of primitive and definitive hematopoietic progenitors from human pluripotent stem cells, J. Vis. Exp., 10.3791/55196 · DOI
  11. Ditadi, 2016, Directed differentiation of definitive hemogenic endothelium and hematopoietic progenitors from human pluripotent stem cells, Methods, 101, 65, 10.1016/j.ymeth.2015.10.001 · DOI
  12. Ditadi, 2017, A view of human haematopoietic development from the Petri dish, Nat. Rev. Mol. Cell Biol., 18, 56, 10.1038/nrm.2016.127 · DOI
  13. Ditadi, 2015, Human definitive haemogenic endothelium and arterial vascular endothelium represent distinct lineages, Nat. Cell Biol., 17, 580, 10.1038/ncb3161 · DOI
  14. Dou, 2016, Medial HOXA genes demarcate haematopoietic stem cell fate during human development, Nat. Cell Biol., 18, 595, 10.1038/ncb3354 · DOI
  15. Foley, 2012, Cytomegalovirus reactivation after allogeneic transplantation promotes a lasting increase in educated NKG2C+ natural killer cells with potent function, Blood, 119, 2665, 10.1182/blood-2011-10-386995 · DOI
  16. Galy, 1995, Human T, B, natural killer, and dendritic cells arise from a common bone marrow progenitor cell subset, Immunity, 3, 459, 10.1016/1074-7613(95)90175-2 · DOI
  17. Gao, 2018, RUNX1 and the endothelial origin of blood, Exp. Hematol., 68, 2, 10.1016/j.exphem.2018.10.009 · DOI
  18. Grzywacz, 2011, Natural killer-cell differentiation by myeloid progenitors, Blood, 117, 3548, 10.1182/blood-2010-04-281394 · DOI
  19. Horowitz, 2013, Genetic and environmental determinants of human NK cell diversity revealed by mass cytometry, Sci. Transl. Med., 5, 208ra145, 10.1126/scitranslmed.3006702 · DOI
  20. Kennedy, 2012, T lymphocyte potential marks the emergence of definitive hematopoietic progenitors in human pluripotent stem cell differentiation cultures, Cell Rep, 2, 1722, 10.1016/j.celrep.2012.11.003 · DOI
  21. Kennedy, 2000, Reversible defects in natural killer and memory CD8 T cell lineages in interleukin 15-deficient mice, J. Exp. Med., 191, 771, 10.1084/jem.191.5.771 · DOI
  22. Kim, 2000, In vivo natural killer cell activities revealed by natural killer cell-deficient mice, Proc. Natl. Acad. Sci. USA, 97, 2731, 10.1073/pnas.050588297 · DOI
  23. Knorr, 2013, Clinical-scale derivation of natural killer cells from human pluripotent stem cells for cancer therapy, Stem Cells Transl. Med., 2, 274, 10.5966/sctm.2012-0084 · DOI
  24. Kondo, 1997, Identification of clonogenic common lymphoid progenitors in mouse bone marrow, Cell, 91, 661, 10.1016/S0092-8674(00)80453-5 · DOI · Paper page
  25. La Motte-Mohs, 2005, Induction of T-cell development from human cord blood hematopoietic stem cells by delta-like 1 in vitro, Blood, 105, 1431, 10.1182/blood-2004-04-1293 · DOI
  26. Lopez-Vergès, 2010, CD57 defines a functionally distinct population of mature NK cells in the human CD56dimCD16+ NK-cell subset, Blood, 116, 3865, 10.1182/blood-2010-04-282301 · DOI · Paper page
  27. Lopez-Vergès, 2011, Expansion of a unique CD57+ NKG2Chi natural killer cell subset during acute human cytomegalovirus infection, Proc. Natl. Acad. Sci. USA, 108, 14725, 10.1073/pnas.1110900108 · DOI · Paper page
  28. Lux, 2008, All primitive and definitive hematopoietic progenitor cells emerging before E10 in the mouse embryo are products of the yolk sac, Blood, 111, 3435, 10.1182/blood-2007-08-107086 · DOI
  29. McGrath, 2015, Distinct sources of hematopoietic progenitors emerge before HSCs and provide functional blood cells in the mammalian embryo, Cell Rep., 11, 1892, 10.1016/j.celrep.2015.05.036 · DOI · Paper page
  30. McGrath, 2011, A transient definitive erythroid lineage with unique regulation of the beta-globin locus in the mammalian embryo, Blood, 117, 4600, 10.1182/blood-2010-12-325357 · DOI
  31. McGrath, 2015, Early hematopoiesis and macrophage development, Semin. Immunol., 27, 379, 10.1016/j.smim.2016.03.013 · DOI
  32. Medvinsky, 1996, Definitive hematopoiesis is autonomously initiated by the AGM region, Cell, 86, 897, 10.1016/S0092-8674(00)80165-8 · DOI
  33. Mehta, 2018, NK cell therapy for hematologic malignancies, Int. J. Hematol., 107, 262, 10.1007/s12185-018-2407-5 · DOI
  34. Miller, 2005, Successful adoptive transfer and in vivo expansion of human haploidentical NK cells in patients with cancer, Blood, 105, 3051, 10.1182/blood-2004-07-2974 · DOI
  35. Murry, 2008, Differentiation of embryonic stem cells to clinically relevant populations: lessons from embryonic development, Cell, 132, 661, 10.1016/j.cell.2008.02.008 · DOI
  36. Ng, 2016, Differentiation of human embryonic stem cells to HOXA+ hemogenic vasculature that resembles the aorta-gonad-mesonephros, Nat. Biotechnol., 34, 1168, 10.1038/nbt.3702 · DOI
  37. Palis, 1999, Development of erythroid and myeloid progenitors in the yolk sac and embryo proper of the mouse, Development, 126, 5073, 10.1242/dev.126.22.5073 · DOI · Paper page
  38. Renoux, 2015, Identification of a human natural killer cell lineage-restricted progenitor in fetal and adult tissues, Immunity, 43, 394, 10.1016/j.immuni.2015.07.011 · DOI
  39. Romee, 2012, Cytokine activation induces human memory-like NK cells, Blood, 120, 4751, 10.1182/blood-2012-04-419283 · DOI
  40. Rosmaraki, 2001, Identification of committed NK cell progenitors in adult murine bone marrow, Eur. J. Immunol., 31, 1900, 10.1002/1521-4141(200106)31:6<1900::AID-IMMU1900>3.0.CO;2-M · DOI
  41. Satoskar, 1999, NK cell-deficient mice develop a Th1-like response but fail to mount an efficient antigen-specific IgG2a antibody response, J. Immunol., 163, 5298, 10.4049/jimmunol.163.10.5298 · DOI
  42. Sturgeon, 2012, Primitive erythropoiesis is regulated by miR-126 via nonhematopoietic Vcam-1+ cells, Dev. Cell, 23, 45, 10.1016/j.devcel.2012.05.021 · DOI
  43. Sturgeon, 2014, Wnt signaling controls the specification of definitive and primitive hematopoiesis from human pluripotent stem cells, Nat. Biotechnol., 32, 554, 10.1038/nbt.2915 · DOI · Paper page
  44. Tang, 2012, Emergence of NK-cell progenitors and functionally competent NK-cell lineage subsets in the early mouse embryo, Blood, 120, 63, 10.1182/blood-2011-02-337980 · DOI
  45. Tavian, 2001, The human embryo, but not its yolk sac, generates lympho-myeloid stem cells: mapping multipotent hematopoietic cell fate in intraembryonic mesoderm, Immunity, 15, 487, 10.1016/S1074-7613(01)00193-5 · DOI
  46. Veluchamy, 2017, The rise of allogeneic natural killer cells as a platform for cancer immunotherapy: recent innovations and future developments, Front. Immunol., 8, 631, 10.3389/fimmu.2017.00631 · DOI
  47. Wagner, 2017, CD56bright NK cells exhibit potent antitumor responses following IL-15 priming, J. Clin. Invest., 127, 4042, 10.1172/JCI90387 · DOI
  48. Woll, 2009, Human embryonic stem cells differentiate into a homogeneous population of natural killer cells with potent in vivo antitumor activity, Blood, 113, 6094, 10.1182/blood-2008-06-165225 · DOI
  49. Yoshimoto, 2011, Embryonic day 9 yolk sac and intra-embryonic hemogenic endothelium independently generate a B-1 and marginal zone progenitor lacking B-2 potential, Proc. Natl. Acad. Sci. USA, 108, 1468, 10.1073/pnas.1015841108 · DOI

Cited by

Sorted by citations

See all 93

Metadata

Authors
Dege, C., Fegan, K. H., Creamer, J. P., Berrien-Elliott, M. M., Luff, S. A., Kim, D., Wagner, J. A., Kingsley, P. D., McGrath, K. E., Fehniger, T. A., Palis, J., & Sturgeon, C. M.
Venue
Developmental Cell
Publisher
Elsevier BV
Published
2020-04
Volume
53
Issue
2
Pages
229-239.e7
ISSN
1534-5807
DOI
10.1016/j.devcel.2020.02.016
PMC
PMC7185477
Cited by
93
References
3
Language
en
Licence
Funders
  • National Heart, Lung, and Blood Institute (HL007088-41)
  • American Cancer Society (IRG-58-010-59-2)
  • National Center for Advancing Translational Sciences (UL1TR002345)
  • National Institutes of Health (DK09361)
  • Center of Regenerative Medicine, Washington University in St. Louis
  • University of Rochester
  • Center for Cellular Imaging, Washington University
  • American Society of Hematology

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review